deltatrials
Completed PHASE2 INTERVENTIONAL NCT00666172

Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Atherosclerosis Diabetes Mellitus Dyslipidemia Hypertension Obesity
Interventions Exercise Weight Loss
Updated 22 times since 2017 Last updated: Dec 14, 2019 Started: Apr 8, 2008 Primary completion: Nov 1, 2012 Completion: Nov 1, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Atherosclerosis and Diabetes Mellitus, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 22 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

22 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Dec 2019 — Jan 2020 [monthly]

    Completed PHASE2

▶ Show 17 earlier versions

  1. Nov 2019 — Dec 2019 [monthly]

    Completed PHASE2

  2. Oct 2019 — Nov 2019 [monthly]

    Completed PHASE2

  3. Sep 2019 — Oct 2019 [monthly]

    Completed PHASE2

  4. Aug 2019 — Sep 2019 [monthly]

    Completed PHASE2

  5. Jul 2019 — Aug 2019 [monthly]

    Completed PHASE2

  6. Jun 2019 — Jul 2019 [monthly]

    Completed PHASE2

  7. May 2019 — Jun 2019 [monthly]

    Completed PHASE2

  8. Apr 2019 — May 2019 [monthly]

    Completed PHASE2

  9. Mar 2019 — Apr 2019 [monthly]

    Completed PHASE2

  10. Feb 2019 — Mar 2019 [monthly]

    Completed PHASE2

  11. Dec 2018 — Feb 2019 [monthly]

    Completed PHASE2

  12. Oct 2018 — Dec 2018 [monthly]

    Completed PHASE2

  13. Sep 2018 — Oct 2018 [monthly]

    Completed PHASE2

  14. Aug 2018 — Sep 2018 [monthly]

    Completed PHASE2

  15. Jul 2018 — Aug 2018 [monthly]

    Completed PHASE2

  16. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE2

  17. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations